Co-Processed Silicified Microcrystalline Cellulose (SMCC)

Advanced Particle Synergy for Demanding Solid Dose Formulations

When standard Microcrystalline Cellulose (MCC) reaches its performance limits with challenging active pharmaceutical ingredients (APIs), Silicified Microcrystalline Cellulose (SMCC) provides the critical physical upgrade required for modern high-speed tableting.

By strategically working with global leading manufacturing partners, we supply a premium, highly engineered SMCC that solves the classic trade-offs between powder flow, compactibility, and lubrication sensitivity.

What Is Silicified Microcrystalline Cellulose (SMCC)?

SMCC is a high-performance, co-processed excipient comprised of 98% Microcrystalline Cellulose and 2% w/w Colloidal Silicon Dioxide (CSD).

Unlike a standard physical dry blend, this material is manufactured via a specialized co-processing technique. This process creates an intimate, uniform distribution of sub-micron silicon dioxide particles across the surface of the porous MCC aggregates. The resulting particle synergy fundamentally alters the physical properties of the substrate, delivering an optimized particle matrix that cannot be replicated by simple plant-floor mixing.

For more information about SMCC please complete and submit the form below

Key Technical Advantages

  • Enhanced Powder Rheology: The uniform surface distribution of colloidal SiO2 significantly reduces inter-particle friction and cohesive forces. This ensures exceptional, predictable powder flow—even when formulating with sticky, micronized, or highly cohesive APIs.
  • Superior Compactibility & Tensile Strength: SMCC exhibits enhanced plastic deformation characteristics, producing tablets with higher tensile strength at identical compression forces compared to standard MCC. This allows formulators to achieve robust hardness profiles or reduce overall tablet weight.
  • Mitigated Lubricant Sensitivity: A common failure point in direct compression is the loss of compactibility due to over-blending with hydrophobic lubricants like magnesium stearate. SMCC retains its robust binding capability even in heavily lubricated matrices.
  • Moisture Buffering Capability: The integrated silicon dioxide component aids in managing internal moisture distribution, offering a protective buffering effect for moisture-sensitive active ingredients.
  • Optimized Content Uniformity: The optimized surface topography of the co-processed particles helps lock low-dose or high-potency APIs uniformly throughout the blend, preventing segregation during manufacturing transitions.
  • Process Rationalization: By combining the functions of a binder and a high-efficiency glidant into a single composite material, SMCC reduces raw material SKU counts, simplifies weighing steps, and streamlines inventory management.

Primary Applications

  • Direct Compression (DC): The premier choice for direct compression lines, particularly when running high-speed presses with difficult, poorly flowing active ingredients.
  • High-Potency & Low-Dose Formulations: Ideal for solid dosage forms requiring stringent content uniformity and precise micro-dose distribution.
  • Lubrication-Sensitive Systems: Formulations utilizing high concentrations or extended blending cycles of metallic stearate lubricants.
  • Modified and Controlled Release Matrices: Provides a predictable, robust structural scaffold for oral solid dosage forms.
  • Capsule Filling: Enhances volumetric die-filling consistency on automated capsule filling equipment due to superior flow characteristics.

Secure, Compliant Global Supply

We bridge the gap between world-class manufacturing precision and localized supply chain reliability. By sourcing from globally accredited, cGMP-certified production facilities with massive scale capacity, we ensure your production lines remain uninterrupted.

  • Full regulatory compliance with international pharmacopoeial standards (USP/NF, Ph. Eur., JP).
  • Complete technical documentation suites provided with every batch, including comprehensive Certificates of Analysis (CoA), SDS, and regulatory declarations.
  • Reliable bulk inventory availability to support seamless scale-up from pilot batches to commercial volumes.

Technical FAQ

  • Q. How does co-processed SMCC differ from a standard physical blend of MCC and silica?
    A. A physical blend simply mixes separate particles, which are highly prone to segregation during transport and hopper feeding, leading to inconsistent flow and tablet defects. Co-processed SMCC binds the colloidal silicon dioxide intimately to the MCC structure at a microscopic level, ensuring a completely homogeneous composite that remains uniform throughout the entire manufacturing cycle.
  • Q. When should formulators switch from standard MCC to SMCC?
    A. SMCC should be specified when standard MCC grades fail to provide adequate flow through the feed frame, when tablet capping or low hardness occurs at high press speeds, or when the API is highly cohesive, sticky, or sensitive to lubricant over-mixing.
  • Q. Does the use of SMCC impact the dissolution profile of the final tablet?
    A. No. Despite the significantly increased tablet hardness and tensile strength achieved with SMCC, the high internal porosity of the composite particles maintains rapid water wicking and excellent disintegration characteristics, preserving optimal API dissolution profiles.